Cefaly Technology
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Cefaly Technology sits in the upper quartile of US sponsors by registered trial count (#1,806 of 15,742 sponsors by registered trial count).
Cefaly Technology: 7 sponsored US clinical trials, 1 recruiting.
Cefaly Technology sponsors 7 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 6 completed. 0 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Migraine, with 3 trials.
Upper-quartile sponsor footprint
Cefaly Technology sits in the upper quartile of the sponsor corpus (#1,806 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
7 total, page 1 of 1
External Trigeminal Nerve Stimulation for Migraine Treatment in Pregnancy
NCT06788977
A Phase III Trial of e-TNS for the Acute Treatment of Migraine
NCT03465904
Abortive Treatment of Migraine With the Cefaly® Abortive Program Device
NCT03217968
Acute Treatment of Migraine With e-TNS
NCT02590939
Cefaly® Device in the Treatment of Patients With Fibromyalgia.
NCT02546362
Acute Treatment of Migraine Using the CEFALY Device
NCT02411513
Open-trial on the Prevention of Chronic Migraines With the CEFALY Device
NCT02342743
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
Therapeutic Areas
What is open in the Cefaly Technology pipeline
1 recruiting of 7 indexed (14% open); 6 completed (86%).
Phase mix: 0 late (III/IV) vs 1 early (I/II) (early-phase heavy).
Top condition: Migraine (3 trials), 5 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Cefaly Technology: open-pipeline peers nationwide
Peers matched on 7 registered trials and 14% open enrollment, not the therapeutic-area sidebar.
Cefaly Technology sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 7 trials (± recruiting share)
- 3M · 7 trials · 0% recruiting
- 4Life Research · 7 trials · 0% recruiting
- 89bio · 7 trials · 29% recruiting
- Abbott Diagnostics Division · 7 trials · 0% recruiting
Sponsors near 14% open enrollment (± trial volume)
- Academic and Community Cancer Research United · 14% recruiting · 42 trials
- Adaptive Biotechnologies · 14% recruiting · 7 trials
- AgelessRx · 14% recruiting · 7 trials
- Alaska Blind Child Discovery · 14% recruiting · 7 trials
Related
What to do with this Cefaly Technology page
7 registered trials is a research-attention snapshot, not an endorsement of Cefaly Technology or any single study.
- 1 of Cefaly Technology's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Migraine is the condition Cefaly Technology studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Migraine trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Cefaly Technology pipeline card: 7 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.